Superior rejection profile during the first 24 months after heart transplantation under tacrolimus as baseline immunosuppressive regimen

BACKGROUND: The use of tacrolimus (TAC) in patients after heart transplantation (HTX) has increased over the last few years. AIM: In this retrospective study, we evaluated the effects of a TAC (conventional and extended-release TAC)-based immunosuppressive therapy regarding rejection profile in comp...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Helmschrott, Matthias, Beckendorf, Jan, Akyol, Ceylan, Ruhparwar, Arjang, Schmack, Bastian, Erbel, Christian, Gleissner, Christian A, Akhavanpoor, Mohammadreza, Ehlermann, Philipp, Bruckner, Tom, Katus, Hugo A, Doesch, Andreas O
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2014
Témata:
Original Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4166906/
https://ncbi.nlm.nih.gov/pubmed/25246772
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S68542
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky